Additionally, it addresses the FDA’s communications Together with the applicant, the retention of data that help the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of an SE report to a completely new applicant and electronic submission of the SE report an